HSBC Holdings’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Sell
119,006
-36,579
-24% -$283K ﹤0.01% 1802
2026
Q1
$976K Buy
155,585
+8,814
+6% +$61.3K ﹤0.01% 1873
2025
Q4
$1.03M Sell
146,771
-73,487
-33% -$443K ﹤0.01% 1927
2025
Q3
$1.2M Buy
220,258
+72,173
+49% +$354K ﹤0.01% 1726
2025
Q2
$751K Buy
148,085
+35,896
+32% +$215K ﹤0.01% 1947
2025
Q1
$743K Buy
112,189
+6,182
+6% +$47K ﹤0.01% 1886
2024
Q4
$789K Buy
106,007
+15,368
+17% +$110K ﹤0.01% 1925
2024
Q3
$632K Buy
90,639
+67,981
+300% +$409K ﹤0.01% 1899
2024
Q2
$110K Buy
22,658
+329
+1% +$1.98K ﹤0.01% 2714
2024
Q1
$138K Buy
22,329
+6,729
+43% +$45.3K ﹤0.01% 2772
2023
Q4
$123K Buy
+15,600
New +$101K ﹤0.01% 2565

Other funds holding LFST

HSBC Holdings's LFST Position: Q2 2026 in Review

HSBC Holdings reduced its Lifestance Health (LFST) stake by 24% in Q2 2026, selling an estimated $283K and leaving 119,006 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1802.

HSBC Holdings first reported a position in LFST in Q4 2023 and has held it in 11 quarters since. 288 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • HSBC Holdings held 119,006 shares of Lifestance Health worth $1.29M as of Q2 2026.
  • HSBC Holdings sold 36,579 Lifestance Health shares in Q2 2026, an estimated $283K.
  • Lifestance Health made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1802 holding.
  • HSBC Holdings first reported a position in Lifestance Health in Q4 2023 and has held it in 11 quarters since.
  • 288 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.